Arthrex Asks USPTO Director To Review 2017 PTAB Decision
In the wake of the U.S. Supreme Court's Arthrex decision, the U.S. Patent and Trademark Office director has been asked by Arthrex Inc. itself to review a 2017 ruling invalidating two...To view the full article, register now.
Already a subscriber? Click here to view full article